Lesson plan
1BP-LSD
1BP-LSD, also known as 1-(3-(tetramethyldioxaborolane)propionyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to be a prodrug of LSD. The drug was encountered online as a novel designer drug in December 2025. 1BP-LSD has been sold in the form of blotter containing 175 and 200 μg per tab. It has been said to be considered to be the official legal successor of 1S-LSD, which was banned in Germany soon before 1BP-LSD's appearance. The effects of 1BP-LSD are said to be similar to those of 1S-LSD and to include visual changes, altered perception of time and space, heightened emotions, and increased creativity. 1BP-LSD is not an explicitly controlled substance in the United States or in Canada.
Article summary
1BP-LSD, also known as 1-(3-(tetramethyldioxaborolane)propionyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to be a prodrug of LSD. The drug was encountered online as a novel designer drug in December 2025. 1BP-LSD has been sold in the form of blotter containing 175 and 200 μg per tab. It has been said to be considered to be the official legal successor of 1S-LSD, which was banned in Germany soon before 1BP-LSD's appearance. The effects of 1BP-LSD are said to be similar to those of 1S-LSD and to include visual changes, altered perception of time and space, heightened emotions, and increased creativity. 1BP-LSD is not an explicitly controlled substance in the United States or in Canada.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.